市场调查报告书
商品编码
1463736
2030 年亚太地区减重手术市场预测 - 区域分析 - 按类型和最终用户(医院和门诊手术中心)Asia Pacific Bariatric Surgeries Market Forecast to 2030 - Regional Analysis - by Type and End User (Hospitals and Ambulatory Surgical Centers) |
2022年亚太减重手术市场价值为9.1353亿美元,预计2030年将达到31.1501亿美元;预计2022年至2030年CAGR为16.6%。
市场参与者的策略性倡议推动亚太减重手术市场
全球肥胖盛行率不断上升,这增加了对减肥手术设备的需求。各种市场参与者也专注于产品发布或策略合作,以开发有助于减肥手术并提供积极成果的先进产品。近年来出现了各种新的发展,例如产品发布、合併和收购。其中一些如下: 2022年11月,波士顿科学公司以总价值约6.15亿美元收购Apollo Endosurgery Inc.,相当于每股10美元的现金价格。 Apollo Endosurgery 产品组合包括腔内手术 (ELS) 过程中使用的设备,用于闭合和管理胃肠道缺陷和併发症,以及帮助肥胖患者减肥。 2021 年 9 月,奥林巴斯收购了名为 POWERSEAL 的新型先进双极手术能量产品系列。 POWERSEAL 5 mm 弯曲下颚组织密封器和分隔器是一种双作用设备,透过以符合人体工学和多功能设计的方式提供恆定的密封可靠性,从而提高手术效率,满足先进双极手术能量设备的最高医疗性能标准。 POWERSEAL 装置可用于多种外科手术,包括一般外科、妇科、结直肠、减重、泌尿外科、胸部和血管外科手术。
因此,产品发布、开发和策略合作的激增可能会在未来为减重手术设备市场创造可观的成长机会。
亚太地区减重手术市场概况
亚太减肥手术市场分为中国、日本、印度、韩国、澳洲和亚太其他地区。减重手术市场的成长广泛受到公司合作、肥胖盛行率增加以及对微创手术需求不断增长的推动。由于中国肥胖人口不断增长,减肥手术在中国获得了巨大的关注。其他因素,例如糖尿病的增加、心血管疾病 (CVD) 病例的增加以及市场参与者的发展也主要促进了该国减肥手术设备的增长,使其成为亚太地区的重要市场。
2022年9月,根据《全球健康杂誌》报道,肥胖已成为全球严重的公共卫生问题。中国是世界上超重人数最多的国家。中国超过50%的成年人和约20%的儿童和青少年体重超重。近20年来,我国在肥胖干预方面采取了多项行动,肥胖率持续成长。因此,中国对减重手术的需求正在成长。
一些市场参与者正在采取有机策略来保持市场竞争力。例如,2021 年 9 月,Olympus推出了 POWERSEAL 5mm 弯曲下颚组织密封器和分割器。该设备透过符合人体工学的多功能设计提供一致的密封可靠性,从而提高手术效率,满足先进双极手术能量设备的最高临床性能标准。
上述因素可能会持续推动中国减重手术设备市场的成长。
亚太地区减重手术市场收入及 2030 年预测(百万美元)
亚太地区减重手术市场区隔
亚太地区减重手术市场按类型、最终用户和国家进行细分。
根据类型,亚太地区减重手术市场分为可调式胃束带(AGB)、袖状胃切除术、胃绕道手术、十二指肠开关胆胰改道术(bpd-ds)等。 2022 年,袖状胃切除术细分市场占据最大份额。
就最终用户而言,亚太地区减重手术市场分为医院和门诊手术中心。 2022 年,医院细分市场将占据更大份额。
依国家划分,亚太地区减重手术市场分为中国、日本、印度、韩国、澳洲和亚太地区其他地区。 2022年,中国在亚太减重手术市场占据主导地位。
Conmed Corp、Integra LifeSciences Holdings Corp、Intuitive Surgical Inc、Medtronic Plc、Olympus Corp 和 Reshape Lifesciences Inc 是亚太减肥手术市场上的一些领先公司。
表中的内容
The Asia Pacific bariatric surgeries market was valued at US$ 913.53 million in 2022 and is expected to reach US$ 3,115.01 million by 2030; it is estimated to grow at a CAGR of 16.6% from 2022 to 2030.
Strategic Initiatives by Market Players Fuels the Asia Pacific Bariatric Surgeries Market
There has been a constant increase in the prevalence of obesity on a global level that has increased the demand for bariatric surgery devices. Various market players are also focused on product launches or strategic collaborations for the development of advanced products that help during bariatric surgeries and provide positive outcomes. There have been various recent developments, such as product launches, mergers, and acquisitions in recent years. A few of them are mentioned below: In November 2022, Boston Scientific Corporation acquired Apollo Endosurgery Inc. with a total value of approximately US$ 615 million, which indicated a cash price of US$ 10 per share. The Apollo Endosurgery product portfolio includes devices used during endoluminal surgery (ELS) procedures to close and manage gastrointestinal defects and complications, along with aid in weight loss for patients with obesity. In September 2021, Olympus acquired the new advanced bipolar surgical energy product range known as POWERSEAL. The POWERSEAL 5 mm Curved Jaw Tissue Sealer and Divider is a double-action device that meets the highest standards of medical performance for advanced bipolar surgical energy devices by delivering constant sealing reliability in an ergonomic and multifunctional design that promotes procedural efficiency. The POWERSEAL devices can be employed in numerous surgical procedures, including general, gynaecological, colorectal, bariatric, urological, thoracic, and vascular surgical procedures.
Thus, a surge in product launches, development, and strategic collaborations is likely to create considerable growth opportunities for the bariatric surgery devices market in the future.
Asia Pacific Bariatric Surgeries Market Overview
The Asia Pacific bariatric surgeries market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The growth of the bariatric surgeries market is widely driven by company collaborations, increasing prevalence of obesity, and growing demand for minimally invasive surgeries. Due to the growing obese population in China, bariatric surgeries are gaining significant traction in the country. Other factors such as growing diabetes, rising cases of cardiovascular diseases (CVDs), and developments by the market players are also majorly contributing to the growth of bariatric surgery devices in the country, making it a significant market in Asia Pacific.
In September 2022, according to the Global Health Journal, obesity has become a severe public health issue worldwide. China has the world's largest number of overweight people. Over 50% of adults and about 20% of children and adolescents in China are overweight. Over the past 20 years, China has taken many actions in obesity intervention, and obesity rates have continued to grow. Thus, the demand for bariatric surgeries is growing in China.
Several market players are adopting organic strategies to stay competitive in the market. For instance, in September 2021, Olympus launched the POWERSEAL 5mm Curved Jaw Tissue Sealer and Divider. The devices fulfil the highest clinical performance standards for advanced bipolar surgical energy devices by delivering consistent sealing reliability in an ergonomic, multifunctional design that encourages procedural efficiency.
The factors mentioned above are likely to continue to boost the growth of the bariatric surgery devices market in China.
Asia Pacific Bariatric Surgeries Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Bariatric Surgeries Market Segmentation
The Asia Pacific bariatric surgeries market is segmented into type, end user, and country.
Based on type, the Asia Pacific bariatric surgeries market is categorized adjustable gastric bands (AGB), sleeve gastrectomy, gastric bypass, biliopancreatic diversion with duodenal switch (bpd- ds), and others. The sleeve gastrectomy market segment held the largest share in 2022.
In terms of end user, the Asia Pacific bariatric surgeries market is bifurcated into hospitals and ambulatory surgical centers. The hospitals segment held a larger share in 2022.
Based on country, the Asia Pacific bariatric surgeries market is segmented China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific bariatric surgeries market in 2022.
Conmed Corp, Integra LifeSciences Holdings Corp, Intuitive Surgical Inc, Medtronic Plc, Olympus Corp, and Reshape Lifesciences Inc are some of the leading companies operating in the Asia Pacific bariatric surgeries market.
Table of Content